PBYI
PUMA BIOTECHNOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.60
+0.84%Forward multiples
Based on analyst estimates
- P/E forward
- 30.00x
- P/E 2026E
- 24.91x
- P/E 2027E
- 47.32x
- P/E 2028E
- 63.10x
- P/S forward
- 3.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.90x
- PEG TTM
- 0.08x
- Price / book
- 3.58x
- Price / sales
- 2.14x
- Price / cash flow
- 12.04x
Enterprise value
- Enterprise value
- $406.5M
- EV / sales
- 1.76x
- EV / EBITDA
- 8.53x
- EV / EBIT
- 13.35x
- Market cap
- $495.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026